No abstract available
Publication types
-
Multicenter Study
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Cyclophosphamide / therapeutic use
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
-
Rituximab / therapeutic use
-
Vidarabine / therapeutic use
Substances
-
Rituximab
-
ibrutinib
-
fludarabine
-
Cyclophosphamide
-
Vidarabine